Dendrimers get cerebral

U.S. researchers have developed a dendrimer-based therapy that reduced brain inflammation and improved the motor function of newborn rabbits with cerebral palsy.¹ The team now needs to determine the therapy's treatment window and its efficacy in the multiple types of cerebral palsy.

Cerebral palsy encompasses a group of disorders characterized by motor impairments that result from damage to the fetal or infant brain. The most common causes of the disease are intrauterine infection, prenatal hypoxia, trauma during delivery and premature birth...